Opticrom

Urticaria Pigmentosa, Asthma, Keratoconjunctivitis + 9 more

Treatment

20 Active Studies for Opticrom

Treatment for

Urticaria Pigmentosa

What is Opticrom

Cromoglicic acidThe Generic name of this drug

Treatment SummaryCromolyn is a medication used to prevent asthma attacks. It works by blocking the release of certain chemicals from cells that cause asthma symptoms. Cromolyn can be used to prevent allergies and exercise-induced asthma, but it cannot stop an asthma attack that has already started.

Intalis the brand name

image of different drug pills on a surface

Opticrom Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Intal

Cromoglicic acid

1982

45

Effectiveness

How Opticrom Affects PatientsCromoglicate (also known as cromolyn) is a synthetic drug used to treat asthma, allergic rhinitis, conjunctivitis, systemic mastocytosis, and ulcerative colitis. It works by preventing the airways from narrowing during an asthma attack or allergic reaction. It is available as an eye drop and as an oral medication.

How Opticrom works in the bodyCromoglicate reduces the severity of allergic reactions. It does this by blocking the release of histamine and other substances from mast cells. It may also reduce inflammation by blocking calcium from entering the cell.

When to interrupt dosage

The suggested dosage of Opticrom is contingent upon the recognized condition, including Urticaria Pigmentosa, Exercise-Induced Bronchospasm and Conjunctivitis, Vernal. The measure of dosage is reliant upon the technique of delivery (e.g. Liquid; Spray or Respiratory (inhalation)) indicated in the table below.

Condition

Dosage

Administration

Conjunctivitis, Vernal

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Urticaria Pigmentosa

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Asthma

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Keratoconjunctivitis

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Bronchospasm, Exercise-Induced

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Food Allergy

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Exercise-Induced Bronchospasm

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Perennial Allergic Rhinitis (PAR)

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Hypersensitivity

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Hay Fever

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Seasonal Allergic Conjunctivitis

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Vernal Keratoconjunctivitis

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Warnings

There are 1 known major drug interactions with Opticrom.

Common Opticrom Drug Interactions

Drug Name

Risk Level

Description

Methacholine

Minor

Cromoglicic acid may decrease effectiveness of Methacholine as a diagnostic agent.

Opticrom Toxicity & Overdose RiskOverdosing on Sudafed can cause coughing, stuffy nose, nausea, sneezing, and difficulty breathing.

image of a doctor in a lab doing drug, clinical research

Opticrom Novel Uses: Which Conditions Have a Clinical Trial Featuring Opticrom?

157 active clinical trials are currently assessing the effectiveness of Opticrom in providing relief for Asthma, Vernal Keratoconjunctivitis, and Seasonal Allergic Conjunctivitis.

Condition

Clinical Trials

Trial Phases

Asthma

160 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 4, Early Phase 1, Phase 3

Conjunctivitis, Vernal

1 Actively Recruiting

Phase 4

Vernal Keratoconjunctivitis

0 Actively Recruiting

Bronchospasm, Exercise-Induced

0 Actively Recruiting

Hypersensitivity

0 Actively Recruiting

Keratoconjunctivitis

3 Actively Recruiting

Phase 2, Phase 3

Urticaria Pigmentosa

0 Actively Recruiting

Perennial Allergic Rhinitis (PAR)

1 Actively Recruiting

Phase 3

Exercise-Induced Bronchospasm

1 Actively Recruiting

Phase 2

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Hay Fever

1 Actively Recruiting

Phase 3

Food Allergy

7 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 3

Opticrom Reviews: What are patients saying about Opticrom?

5Patient Review

2/25/2019

Opticrom for Inflamed Cornea & Conjunctiva of Eye due to Allergies

This product saved me from five or six more days of itchy, inflamed eyes. Within hours of using it, my eyes were back to normal. I'll definitely be keeping a spare bottle on hand from now on!

4.7Patient Review

11/23/2016

Opticrom for Allergic Conjunctivitis

3Patient Review

12/19/2019

Opticrom for Giant Papillary Conjunctivitis

It took over a month of using this treatment before I saw any real results, and even then they were slow in coming. Unfortunately, I also developed styes in one of my eyes.

Patient Q&A Section about opticrom

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is opticrom prescription only?

"Opticrom is a drug used to relieve the symptoms of conjunctivitis. It may be used by itself or in combination with other drugs. Mast cell stabilizers are a class of drugs to which Opticrom belongs."

Answered by AI

How many times a day can you use opticrom?

"Using this medicine: -Administer one or two drops into each eye four times daily -Do not use in children under 6 years of age -If you have any questions about using this medicine on a child or if you think the child may have allergic eyes, speak to your doctor or pharmacist."

Answered by AI

How long can you use opticrom eye drops?

"If you are using this medication in only one eye, clean the applicator after each use.

Apply this medication in the affected eye(s), usually 4 times daily or as directed by your doctor. Treatment may be continued for as long as 3 months.

If you are using this medication in only one eye, clean the applicator after each use."

Answered by AI

What is opticrom used for?

"Opticrom Allergy Single Dose 2% w/v Eye Drops, solution is a medicine used to relieve and treat eye allergies in adults and children. The active ingredient is sodium cromoglicate, which belongs to a group of medicines called anti allergics."

Answered by AI

Clinical Trials for Opticrom

Image of GSK Investigational Site in Little Rock, United States.

Inhaled corticosteroids/long-acting beta-2 agonists +1 More for Asthma

Little Rock, AR

"This trial aims to see how well a new medication, FF/UMEC/VI, works compared to the standard treatment, ICS/LABA, in adults with uncontrolled asthma."

Waitlist Available

GSK Investigational Site (+29 Sites)GlaxoSmithKline

Image of Phoenix Children's in Phoenix, United States.

NOVELOSETM 3490 for Childhood Asthma

"This trial will investigate the effects of soluble fiber on asthma. Participants will be given either soluble fiber or a placebo, and their gut microbes will be analyzed through blood, fecal, and nasal samples.

Phoenix Children'sMatthew Rank

Image of Southern California Research in California City, United States.

Lebrikizumab for Allergic Rhinitis

California City, CA

"This trial aims to test if lebrikizumab is effective and safe for adults with year-round allergic rhinitis. The study will take around 13 months to complete."

Waitlist Available

Southern California Research (+15 Sites)Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of School of Public Health-Bloomington in Bloomington, United States.

PrO2Fit Device for Exercise-Induced Asthma

Bloomington, IN

This trial aims to investigate whether training the muscles we use to breathe in can help people with exercise-induced breathing problems. The study will look at how this training affects the severity of breathing issues during exercise,

School of Public Health-BloomingtonTim Mickleborough, Ph.D.

Have you considered Opticrom clinical trials? We made a collection of clinical trials featuring Opticrom, we think they might fit your search criteria.

Explore trials for Opticrom

Image of Research Site in White Marsh, United States.

Budesonide/Albuterol Metered-Dose Inhaler for Asthma

White Marsh, MD

This trial aims to see if using a specific inhaler, budesonide/albuterol, works better than a regular albuterol inhaler in treating severe asthma attacks in teenagers aged

Waitlist Available

Research SiteParexel

Image of University of Michigan in Ann Arbor, United States.

Control group Adult for Atopic Dermatitis

"This trial aims to investigate the relationship between atopic dermatitis and food allergy. By collecting blood and skin samples from participants, the study seeks to understand if these conditions have common genetic or biochemical markers that

University of MichiganChase Schuler, MD

Image of Teva Investigational Site 12001 in Boerne, United States.

Fluticasone Propionate +1 More for Asthma

This trial aims to study how the drugs fluticasone propionate (Fp) and albuterol sulfate (ABS) work together when taken as a single dose using a dry powder inhal

Teva Investigational Site 12001Teva Medical Expert, MDTeva Branded Pharmaceutical Products R&D, Inc.

Image of DARTNet Insitute in Aurora, United States.

Inhaled Steroids +1 More for Immune System Disorders

"This trial is testing different treatments for teenagers and adults with asthma. Participants will be randomly assigned to one of four groups: enhanced usual care, rescue inhaled corticosteroids, azithromycin

DARTNet InsituteDavid T Mauger, PhD

Have you considered Opticrom clinical trials? We made a collection of clinical trials featuring Opticrom, we think they might fit your search criteria.

Explore trials for Opticrom

Image of GSK Investigational Site in Aventura, United States.

Salbutamol for Asthma

This trial will check if two different types of salbutamol inhalers are safe and well-tolerated for people 12 years and older with asthma.

Waitlist Available

GSK Investigational Site (+34 Sites)GlaxoSmithKline

Image of Children's Hospital Colorado in Aurora, United States.

Nav-Team for Childhood Asthma

This trial is looking at a program called Nav-Team that aims to help asthmatic children and their caregivers by providing additional assistance and education. The study will work with community organizations to tailor the program

Waitlist Available

Children's Hospital Colorado

Image of Johns Hopkins All Children's Hospital in Saint Petersburg, United States.

Azithromycin for Asthma

Saint Petersburg, FL

This trial will examine how Azithromycin affects the immune system in children with severe asthma.

Johns Hopkins All Children's HospitalAnthony A Sochet, MD

Image of 1440 Empire Central, Ste. LD4.100 in Dallas, United States.

Escitalopram for Asthma

This trial will assess the effects of a medication called escitalopram, which is commonly used to treat mood and anxiety disorders, on asthma. Previous studies have shown that this medication may help reduce asthma

Waitlist Available

1440 Empire Central, Ste. LD4.100Sherwood Brown, M.D, Ph.D

Have you considered Opticrom clinical trials? We made a collection of clinical trials featuring Opticrom, we think they might fit your search criteria.

Explore trials for Opticrom

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security